First Patients Treated in XLRP Gene Therapy Trial
Tuesday, September 17 2024 | 14 h 31 min | Vision Science
Beacon Therapeutics, has announced that they have treated the first patients in their Phase 2/3 VISTA trial for a gene therapy for X-linked...
Read More
New Gene Replacement Clinical Trial Launched for RP Test
Tuesday, September 3 2024 | 08 h 46 min | Vision Science & Research
ViGeneron in Munich, Germany has launched a new Phase 1b clinical trial testing a novel gene replacement therapy in individuals affected by...
Read More
New Treatment Target for AMD Identified
Tuesday, July 9 2024 | 13 h 35 min | Vision Science & Research
For people living with wet age-related macular degeneration (AMD), the first line of treatment is anti-VEGF injections Anti-VEGF injections have...
Read More Clinical Trial Results for New Treatments for AMD and DME
Tuesday, May 14 2024 | 11 h 17 min | Clinical Practice
Anti-VEGF medications can prevent vision loss and even restore some vision for age-related macular degeneration (AMD) patients However, they require...
Read More Oral Drug Slows Stargardt Disease Progression in Phase 2 Clinical Trial
Tuesday, March 5 2024 | 08 h 05 min | Vision Science & Research
Results from a Phase 2 clinical trial show that an oral drug, Tinlarebant, may slow progression of Stargardt disease Belite Bio, a...
Read More
